The DOI matches its Crossref record.
Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein‐I or autologous bone marrow
Open accessAbstract
Hydroxyapatite is a synthetic bone graft, which is used for the treatment of bone defects and nonunions. However, it is a rather inert material with no or little intrinsic osteoinductive activity. Recombinant human osteogenic protein‐1 (rhOP‐1) is a very potent biological agent, that enhances osteogenesis during bone repair. Bone marrow contains mesenchymal stem cells, which are capable of new bone formation. Biosynthetic bone grafts were created by the addition of rhOP‐1 or bone marrow to granular porous hydroxyapatite. The performance of these grafts was tested in a sheep model and compared to the results of autograft, which is clinically the standard treatment of bone defects and nonunions. A 3 cm segmental bone defect was made in the tibia and fixed with an interlocking intramedullary nail. There were five treatment groups: no implant (n = 6), autograft (n = 8), hydroxyapatite alone (n = 8), hydroxyapatite loaded with rhOP‐1 (n = 8), and hydroxyapatite loaded with autologous bone marrow (n = 8). At 12 weeks, healing of the defect was evaluated with radiographs, a torsional test to failure, and histological examination of longitudinal sections through the defect. Torsional strength and stiffness of the healing tibiae were about two to three times higher for autograft and hydroxyapatite plus rhOP‐1 or bone marrow compared to hydroxyapatite alone and empty defects. The mean values of both combination groups were comparable to those of autograft. There were more unions in defects with hydroxyapatite plus rhOP‐1 than in defects with hydroxyapatite alone. Although the differences were not significant, histological examination revealed that there was more often bony bridging of the defect in both combination groups and the autograft group than in the group with hydroxyapatite alone. Healing of bone defects, treated with porous hydroxyapatite, can be enhanced by the addition of rhOP‐1 or autologous bone marrow. The results of these composite biosynthetic grafts are equivalent to those of autograft. © 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bone Grafts and Bone Graft Substitutes in Orthopaedic Trauma Surgery: A Critical Analysis
De Long, W. G., Einhorn, T. A., Koval, K., McKee, M., Smith, W., Sanders, R., & Watson, T. (2007) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.f.00465 · Cited by 570
How smart do biomaterials need to be? A translational science and clinical point of view
Holzapfel, B. M., Reichert, J. C., Schantz, J.-T., Gbureck, U., Rackwitz, L., Nöth, U., Jakob, F., Rudert, M., Groll, J., & Hutmacher, D. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.009 · Cited by 552
Tadic, D., & Epple, M. (2004) · Biomaterials · doi:10.1016/s0142-9612(03)00621-5 · Cited by 550
The challenge of establishing preclinical models for segmental bone defect research
Reichert, J. C., Saifzadeh, S., Wullschleger, M. E., Epari, D. R., Schütz, M. A., Duda, G. N., Schell, H., van Griensven, M., Redl, H., & Hutmacher, D. W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.050 · Cited by 433
Bone defect animal models for testing efficacy of bone substitute biomaterials
Li, Y., Chen, S.-K., Li, L., Qin, L., Wang, X.-L., & Lai, Y.-X. (2015) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2015.05.002 · Cited by 430
Metadata
- Authors
- den Boer, F. C., Wippermann, B. W., Blokhuis, T. J., Patka, P., Bakker, F. C., & Haarman, H. J. T. M.
- Venue
- Journal of Orthopaedic Research
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 21
- Issue
- 3
- Pages
- 521-528
- ISSN
- 0736-0266 (ISSN-L)
- 1554-527X
- OpenAlex
- W2108312770
- Cited by
- 187
- References
- 0
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein‐I or autologous bone marrow. https://app.cochat.ai/papers/10.1016/s0736-0266(02)00205-x
- The paper
- den Boer, F. C., Wippermann, B. W., Blokhuis, T. J., Patka, P., Bakker, F. C., & Haarman, H. J. T. M. (2003). Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein‐I or autologous bone marrow. Journal of Orthopaedic Research. https://doi.org/10.1016/s0736-0266(02)00205-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.